GlassScriptPhysician profile
Michael G Baraga
NPI 1508067620
$172,918.60
in general payments reported to CMS, 2019-2025
8 companies · $31K in 2025
The $31K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,384 · 2020: $9,825 · 2021: $21K · 2022: $30K · 2023: $51K · 2024: $20K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $92K · Travel and Lodging: $6,231 · Consulting Fee: $2,363 · Food and Beverage: $1,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $91,982.12 |
| Travel and Lodging | $6,231.33 |
| Consulting Fee | $2,362.50 |
| Food and Beverage | $1,446.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $166,548.50 | 2019-2025 | |
| Southern Edge Orthopaedics, INC. | $4,205.67 | 2019-2025 | |
| Lifenet Health | $1,500.00 | 2021 | |
| Bone Support INC. | $154.12 | 2025 | Cerament G, Ceramentbone Void Filler |
| Innovation Technologies INC | $150.58 | 2023 | Irrisept |
| Smith+Nephew, INC. | $127.55 | 2019 | |
| Uoc USA INC | $120.06 | 2020 | |
| Medical Device Business Services, INC. | $112.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Baraga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.